EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Genome-Editing Products Line up for the Market: Will Europe Harvest the Benefits from Science and Innovation?

Alexios Polidoros iD, Irini Nianiou-Obeidat iD, Nikolaos Tsakirpaloglou iD, Nestor Petrou iD, Eleftheria Deligiannidou iD, Nefeli-Maria Makri

Genes · 2024

DOI: 10.3390/genes15081014 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, 2024. Verfasst von Alexios Polidoros und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genetics and Plant Breeding, Faculty of Agriculture, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece. Hauptthemen laut MEDLINE: Gene Editing, Crops, Agricultural, Plants, Genetically Modified, CRISPR-Cas Systems. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technologies have revolutionized genome editing, significantly advancing the improvement of cultivated crop species. This review provides an overview of genome-edited crops that have either reached the market or received the necessary approvals but are not yet available to consumers. We analyze various genome-editing studies to understand the distribution of different genome-editing systems, the types of site-directed nucleases employed, and the geographical spread of these studies, with a specific focus on global and European contexts. Additionally, we examine the target crops involved. The review also outlines the multiple steps required for the legal acceptance of genome-edited crops within European jurisdictions. We conclude with suggestions for the future prospects of genome-editing research in Europe, aiming to streamline the approval process and enhance the development and adoption of genome-edited crops.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingCrops, AgriculturalPlants, Genetically ModifiedCRISPR-Cas SystemsEuropeGenome, PlantHumans

Stichwörter der Autor:innen

CRISPREuropean Union (EU) regulationGenetically Modified Organisms (GMOs)New Genomic Techniques (NGTs)crop improvementproduct commercialization

Autor:innen und Institutionen

  • Laboratory of Genetics and Plant Breeding, Faculty of Agriculture, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.

ORCID-Profile: Alexios Polidoros, Irini Nianiou-Obeidat, Nikolaos Tsakirpaloglou, Nestor Petrou, Eleftheria Deligiannidou

Zitieren

APA

Polidoros, A., Nianiou-Obeidat, I., Tsakirpaloglou, N., Petrou, N., Deligiannidou, E., & Makri, N. M. (2024). Genome-Editing Products Line up for the Market: Will Europe Harvest the Benefits from Science and Innovation?. Genes. https://doi.org/10.3390/genes15081014

Vancouver

Polidoros A, Nianiou-Obeidat I, Tsakirpaloglou N, Petrou N, Deligiannidou E, Makri NM. Genome-Editing Products Line up for the Market: Will Europe Harvest the Benefits from Science and Innovation?. Genes. 2024. doi:10.3390/genes15081014

BibTeX
@article{Polidoros2024,
  author = {Polidoros, Alexios and Nianiou-Obeidat, Irini and Tsakirpaloglou, Nikolaos and Petrou, Nestor and Deligiannidou, Eleftheria and Makri, Nefeli-Maria},
  title = {Genome-Editing Products Line up for the Market: Will Europe Harvest the Benefits from Science and Innovation?},
  journal = {Genes},
  year = {2024},
  doi = {10.3390/genes15081014}
}
Kostenlos starten →